The global glucose monitoring devices market size was valued at USD 13.88 billion in 2025 and is projected to grow from USD 14.57 billion in 2026 to USD 22.64 billion by 2034, exhibiting a CAGR of 5.63% during the forecast period (2026–2034). North America dominated the glucose monitoring devices market with a market share of 39.4% in 2025.
The glucose monitoring devices comprises medical devices and technologies used to measure and monitor blood glucose levels in individuals with diabetes and other metabolic disorders. The market includes continuous glucose monitoring (CGM) systems, self-monitoring blood glucose (SMBG) meters, test strips, lancets, and related accessories. Growth is driven by the rising prevalence of diabetes, increasing adoption of wearable monitoring technologies, advancements in digital healthcare, and growing awareness of proactive glucose management for improved patient outcomes.
Download a Free Sample To learn more about this report,
Growing adoption of continuous glucose monitoring (CGM) and AI-enabled diabetes management technologies
The glucose monitoring devices market trends are being driven by the increasing adoption of continuous glucose monitoring (CGM) systems, wearable sensors, and AI-powered diabetes management platforms. Healthcare providers are shifting from conventional finger-stick blood glucose testing to real-time monitoring solutions that improve glycemic control, enhance patient convenience, and reduce the risk of hypoglycemia. Manufacturers are also focusing on over-the-counter (OTC) CGM devices, extended sensor wear, smartphone connectivity, and cloud-based data sharing to support remote patient monitoring and personalized diabetes care. In addition, the growing integration of glucose monitoring devices with digital health platforms and insulin delivery systems is improving treatment outcomes and enabling more proactive disease management. These advancements are expected to accelerate the adoption of next-generation glucose monitoring technologies worldwide.
These developments indicate that continuous glucose monitoring, AI-enabled diabetes management, wearable digital health technologies, and expanded access to OTC devices will remain the key glucose monitoring devices Market trends driving innovation and improving diabetes care globally.
Rising diabetes prevalence and increasing adoption of continuous glucose monitoring technologies
The glucose monitoring devices market is witnessing robust growth due to the increasing global prevalence of diabetes, growing awareness of blood glucose management, and rapid adoption of continuous glucose monitoring (CGM) systems. Technological advancements in wearable sensors, smartphone-integrated monitoring devices, and AI-powered diabetes management platforms are improving patient outcomes and treatment adherence. Rising healthcare expenditure, supportive reimbursement policies, and expanding access to home-based monitoring solutions are further driving market growth. Increasing demand for personalized diabetes care and remote patient monitoring is also accelerating market expansion.
High device costs and limited reimbursement in developing regions
The glucose monitoring devices market faces restraints due to the high cost of advanced continuous glucose monitoring systems, limited reimbursement coverage in several developing countries, and affordability challenges for long-term device usage. Sensor replacement costs, calibration requirements for certain devices, and disparities in healthcare access also restrict widespread adoption. Regulatory approval complexities and cybersecurity concerns related to connected medical devices further present challenges for manufacturers.
Expansion of AI-enabled glucose monitoring and non-invasive sensing technologies
The glucose monitoring devices market is expected to benefit from the growing adoption of AI-powered diabetes management platforms, non-invasive glucose monitoring technologies, and integrated digital health ecosystems. Increasing investments in wearable biosensors, smartphone-connected monitoring devices, and remote patient management solutions are creating new growth opportunities. Rising demand for personalized healthcare, expansion of telehealth services, and improving healthcare infrastructure in emerging economies are expected to further accelerate market growth.
Maintaining device accuracy, affordability, and long-term patient adherence
The glucose monitoring devices market continues to face challenges related to maintaining sensor accuracy, reducing device costs, and improving long-term patient adherence. Manufacturers must ensure consistent performance across diverse patient populations while complying with stringent regulatory standards. Frequent sensor replacement, interoperability between devices and digital platforms, and expanding cybersecurity requirements continue to increase operational complexity. Additionally, affordability remains a major challenge in low- and middle-income countries, limiting broader adoption of advanced glucose monitoring technologies.
Request Customizationto receive a tailored report.
Self-monitoring Devices Dominated the Market with 58.7% Share in 2025
The Self-monitoring Devices segment accounted for the largest share of the global Glucose Monitoring Devices Market at 58.7% in 2025, driven by their widespread use among diabetic patients for routine blood glucose testing, affordability, and ease of use. Strong demand for portable monitoring devices, increasing awareness of diabetes self-management, and growing availability of user-friendly glucometers continue to support the segment's market leadership across both developed and emerging healthcare markets.
Type 1 Diabetes is Projected to Register the Fastest Growth at a CAGR of 9.7%
The Type 1 Diabetes segment is expected to expand at the fastest CAGR of 9.7% during 2026–2034, supported by rising adoption of continuous glucose monitoring (CGM) systems, increasing prevalence of autoimmune diabetes, and growing emphasis on maintaining tight glycemic control. Technological advancements in wearable glucose monitoring devices and improved reimbursement policies are further accelerating market growth within this segment.
Home Care Settings Dominated the Market with 57.9% Share in 2025
The Home Care Settings segment held the largest market share of 57.9% in 2025, owing to the increasing preference for home-based diabetes management, rising adoption of portable glucose monitoring devices, and the growing need for continuous health monitoring outside clinical settings. Improved patient convenience, expansion of telehealth services, and greater awareness of preventive diabetes care continue to strengthen the segment's dominant position.
Speak to an Analystto discuss market opportunities.
Asia Pacific accounted for 22.8% of the market, reaching USD 3.16 billion in 2025. The region is projected to register the fastest growth at a CAGR of 10.9% during the forecast period. Growth is supported by expanding healthcare infrastructure, rising healthcare expenditure, increasing adoption of advanced medical technologies, and growing investments in healthcare modernization. Improving access to specialized healthcare services and rapid technological advancements continue to strengthen regional market expansion.
China accounted for an estimated USD 1.34 billion in 2025, making it the largest market in Asia Pacific. Growth is driven by expanding healthcare infrastructure, increasing government investments, rising domestic manufacturing capabilities, and growing adoption of advanced medical technologies.
Japan generated an estimated USD 0.73 billion in 2025. The country's advanced healthcare system, aging population, increasing healthcare expenditure, and continuous adoption of innovative medical technologies continue to support steady market growth.
North America dominated the market with a 39.4% market share, valued at USD 5.47 billion in 2025. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, favorable reimbursement policies, and strong research and development activities. Increasing adoption of innovative medical technologies and the presence of leading industry participants continue to drive market growth.
The United States accounted for an estimated USD 4.52 billion of the market in 2025, making it the largest contributor in North America. Growth is driven by increasing healthcare spending, strong clinical research activities, widespread adoption of advanced medical technologies, and continuous product innovation.
Canada generated an estimated USD 0.63 billion in 2025. Rising government healthcare expenditure, increasing investments in medical research, expanding access to advanced healthcare services, and growing adoption of innovative healthcare technologies continue to support market growth.
Europe accounted for 27.1% of the market, reaching USD 3.76 billion in 2025. The market is supported by well-established healthcare systems, increasing investments in medical innovation, favorable regulatory frameworks, and growing demand for advanced healthcare solutions. Continuous research activities and healthcare modernization initiatives are contributing to regional expansion.
Germany led the European market with an estimated value of USD 1.09 billion in 2025. The country's advanced healthcare infrastructure, strong medical technology industry, increasing research investments, and high healthcare expenditure continue to drive market growth.
The United Kingdom represented an estimated USD 0.64 billion in 2025. Growth is driven by increasing NHS investments in healthcare innovation, expanding adoption of advanced healthcare technologies, and rising clinical research activities.
Latin America accounted for 6.2% of the market, reaching USD 0.86 billion in 2025. Rising healthcare expenditure, improving access to specialized healthcare services, expanding healthcare infrastructure, and increasing awareness of advanced treatment solutions are supporting regional market growth.
Brazil accounted for an estimated USD 0.45 billion in 2025, making it the largest market in Latin America. Increasing investments in healthcare infrastructure, expanding private healthcare services, and growing adoption of advanced medical technologies continue to support market expansion.
The Middle East & Africa represented 4.5% of the market, totaling USD 0.62 billion in 2025. Increasing investments in healthcare infrastructure, expanding access to specialized healthcare services, growing adoption of advanced medical technologies, and government initiatives to modernize healthcare systems are supporting regional market growth.
The United Arab Emirates (UAE) accounted for an estimated USD 0.17 billion in 2025. The country's market is driven by government investments in healthcare modernization, expanding private hospital networks, increasing medical tourism, and growing adoption of innovative healthcare technologies.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com